http://www.maniacsolutions.com/212-marketing-solutions-company/
Bioinformatics Markets
The life science informatics marketplace – known as bioinformatics – is set to expand as companies high infiltrate these spaces technology and biopharmaceutical companies incorporate key solutions into their business strategies. The public believes that many segments of bioinformatics described in this report provide a rare opportunity for accelerated expansion in the coming years. This study is prepared to provide an overview of the market segments of bioinformatics and provide evidence that these segments are prepared for the future of major growth. Each segment is accompanied by an analysis and forecasts by product type and application. This analysis examines the market for bioinformatics and the latest information on new emerging products and industry trends. The study to quantify and qualify the bioinformatics market segments as an area of research, development and investment products. Forecasts the bioinformatics market and product analysis of a global market information processing as a basis for understanding the significance of past developments and future possibilities within this market category.
Table of Contents:
1. Information General 8
1.1 Statement of Report 8
1.2 About this Report 8
1.3 Scope of this Report 10
1.4 Methodology 10
1.5 Summary 11 Executive
2. Introduction 13
2.1 Global Bioinformatics Industry Product 14
2.2 Computer Science and Biology 15
2.3 Bioinformatics and Internet 17
2.4 Description of the Assessment Company 17
2.5 Market Prospects 18
2.6 Structure of the competition 20
2.7 Applications of Bioinformatics 20
2.7.1 Medicine 20
22 2.7.2 Microbial Genomics
2.7.3 Agriculture 22
2.8 R & D 22
2.8.1 Allocation of R & D 23
2.8.2 Drugs Traditional discovery process 24
2.8.3 Drug Discovery and Bioinformatics 26
2.8.4 Partnerships 27
2.9 Genome Project Human (HGP) 27
2.9.1 Objectives of the Human Genome Project 27
2.9.2 Benefits of Human Genome Project 29
2.10 Barriers to Entry 29
Proteomics 2.11 and databases 30
31 Rules 2.11.1 Protein Database
2.11.2 Future Trends 32
3. U.S. Bioinformatics 33 Market
3.1 Summary 33
3.2 to market constraints and drivers 35
3.2.1 Market 35 restrictions
3.2.2 Market Drivers 36
4. Genomics 37
4.1 biotechnology 37
4.2 The development of a Genomics Market 39
4.2.1 Market Drivers 40
4.2.2 40 market restrictions
4.2.3 Size Market and Growth Projections 40
4.2.4 The U.S. market Genomics 40
Biochips and 40 4.3 DNA Microarrays
4.3.1 The main challenges 42
Freeware 42 4.3.2
4.3.3 New Tools 43
Bioinformatics 46 4.4
46 4.5 Disease Targets
47 4.6 Functional Genomics
4.7 genetic sequencing 50
4.8 Change detection of genetic sequences 50
51 4.9 Comparative Genomics
4.10 arrays Genome Database 51
Genomic high-performance 4.11 53
4.11.1 Technology High Performance 54
4.11.2 Lab on a chip 54
Pharmacogenomics 4.12 55
4.13 57 probe arrays
4.13.1 observation of gene expression arrays 57
DNA Analysis Arrays 4.13.2 59
60 Proteomics 4.14
Sequencing 61 4.15
4.16 Single nucleotide polymorphisms (SNPs) 61
63 4.17 Structural Genomics
Photolithography 4.18 63
19.4 Instrumentation 64
5. 65 Bioinformatics Industry
5.1 Definition and role of Bioinformatics 65
Bioinformatics 5.1.1 Sector Overview 66
5.1.2 The future status of Bioinformatics 67
5.1.3 Obstacles to Growth 67
5.2 Types of Data and Bioinformatics Applications 67
5.2.1 Core Validated modeling technology 68
69 5.2.2 General Applicability
5.2.3 Data Management Compliant with Industry Standards 69
69 5.2.4 Open Architecture
5.2.5 Ease of use 69
5.2.6 Increased access 69
5.3 Operation of 70 software Bioinformatics
5.3.1 Data Management 70
5.3.2 Data Transformation 70
Collaboration Data 5.3.3 70
5.3.4 Interface for Online Data Sources 70
5.4 The target markets of Computer Software 71
5.5 Steps involved in bringing a drug to market 71
5.6 The costs incurred in developing a new drug 72
5.7 Industry Drivers and Challenges 72
5.8 74 Industry Risks
5.9 Products of Bioinformatics 75
Processes Bioinformatics 76 5.10
Computer 5.11 76 tools and features
5.11.1 Sequence of Structure 76
5.11.2 Lead Identification and Optimization 77
5.11.3 Development and formulation of 77
5.11.4 Materials and Process Improvement 77
5.11.5 Other Materials based on 78 Industries
5.12 Role of Bioinformatics in the Biotechnology Value Chain 78
5.13 Bioinformatics Market Segment 78
5.13.1 78 Databases
80 5.13.2 Hardware
Software 5.13.3 80
Bioinformatics Services 81 5.13.4
5.14 Bioinformatics Market Size 82
5.14.1 sales and R & D 82
5.14.2 IT Budget 83
5.14.3 Projected Bioinformatics Market Size 84
5.15 85 Global Market Perspective
6. Bioinformatics 88 business
Bioinformatics 88 6.1 Business Models
6.1.1 The impact of 89 businesses
Pura 6.1.2 Competition for Computer Companies Play 91
6.1.3 Nonprofit Organizations 91
6.1.4 In-House Bioinformatics Solutions 91
6.1.5 Large Enterprises IT 91
Disciplines 6.2 Bioinformatics Target 92
92 6.2.1 Comparative Genomics
92 6.2.2 Pharmacogenomics
92 6.2.3 Functional Genomics
6.2.4 Proteomics 93
6.2.5 Structural Genomics 94
94 6.2.6 Image Data
95 6.2.7 Clinical Trial Information
95 cheminformatics 6.2.8
Bioinformatics 96 6.3 Architecture
97 6.4 Applications of Bioinformatics
Search Tools 6.4.1 Data 97
6.4.2 Data Visualization Tools 97
6.4.3 Data Mining and 98 clusters
99 6.4.4 Business Solutions
99 6.4.5 Data Storage
6.5 Assessment of Bioinformatics solutions 99
Requirements 6.5.1 Study 99
6.5.2 Options for pre-selection of the 99
6.5.3 Standardization of scoring 100
6.5.4 Performance 101
6.5.5 Data Storage 101
6.5.6 Data Treatment in Drug Discovery 102
Key Issues 6.5.7 Bioinformatics Data Storage 102
6.6 Convergence of Industries 103
6.7 protein as a 104 controller
Bioinformatics 104 6.8 Current Research
New Modeling 6.9 105 Bioinformatics Algorithms
6.10 105 3D Modeling
6.11 106 patents Bioinformatics Algorithms
7. Recent industry activity 109
7.1 Collaborations and Acquisitions 109
7.2 Development 111 products and launches
8. Company profiles 114
Abbott Laboratories 114 8.1
Abgenix 8.2 114
Ablynx 115 8.3
115 8.4 Accelrys
Affimed Therapeutics 117 8.5
Affitech 118 8.6
Affymetrix 118 8.7
Agencourt Bioscience Corporation 119 8.8
120 8.9 Agensys
Agilent Technologies 8.10 120
Alexion Pharmaceuticals 121 8.11
AlgoNomics 8.12 121
Allez Software 8.13 122
Amgen 123 8.14
Antisoma 8.15 124
8.16 Applied Biosystems 124
Arana Therapeutics 126 8.17
Ariadne Genomics 127 8.18
Array Genetics 127 8.19
Astellas Pharma 128 8.20
AstraZeneca 8.21 128
8.22 129 automated processing systems
8.23 Avesthagen, Limited 130
130 Bioalma 8.24
131 8.25 BIOBASE Biological Databases
BioCarta 8.26 132
8.27 Biodatabases (Amita Corporation) 132
133 biodiscovery 8.28
Biogen Idec 133 8.29
BioInformatics 8.30 134
BioInformatics 8.31 135 Services
BioInformatics Solutions 8.32 135
Biomax Informatics 136 8.33
BioServe Technologies 8.34 136
137 Biosiris 8.35
8.36 BioSoftSolutions 137
Biotique Systems 8.37 137
International BioInvent 8.38 138
Biosite Discovery 138 8.39
BioWa 8.40 139
139 BioWisdom 8.41
Bio-Xtal 8.42 140
Boehringer Ingelheim 140 8.43
Cambridge Antibody Technology Group 8.44 141
Capital Genomix 8.45 141
8.46 Celera Group 141
Cellectis 8.47 143
Cellomics 8.48 143
144 CeuticalSoft 8.49
8.50 Chemical Computing Group 145
145 Cimarron Software 8.51
8.52 CLONDIAG Chip Technologies 146
CodonCode Corporation 146 8.53
International CompuDrug 8.54 146
Compugen 8.55 U.S. 147
148 Corimbia 8.56
Crucell 8.57 148
8.58 Bioinformatics CSIRO 149
CuraGen Corporation 149 8.59
151 CyberGene 8.60
Cytogen 8.61 151
International Unlimited Data 151 8.62
DeCODE Genetics 151 8.63
152 Decodon 8.64
Deltagen 8.65 152
Digilab 153 8.66
DNA Software 8.67 154
DNAPrint Genomics 154 8.68
DNA 155 8.69 stars
8.70 DxS 155
Dyax Corp. 156 8.71
Eisai 8.72 157
157 Elan Corporation 8.73
Electric Genetics Corporation 159 8.74
Elusys Therapeutics 160 8.75
160 Entagen 8.76
Entelos 8.77 160
Enzon Pharmaceuticals 161 8.78
Epigenomics 8.79 162
Computer epitope 163 8.80
Biosciences 8.81 EraGen 163
8.82 European Bioinformatics Institute (EBI) 163 Industry Program
164 8.83 Evolutionary Bioinformatics
Genamics 8.84 164
8.85 164 GeneData
165 8.86 Gene Logic
Genentech 8.87 167
8.88 Geneva Bioinformatics (GeneBio) 168
Genmab 8.89 169
GenOdyssee 8.90 170
170 Genolyze 8.91
Genomatica 8.92 171
GenomeQuest 8.93 171
172 8.94 Genomic Solutions
173 Genomining 8.95
8.96 Genovac 173
8.97 Genzyme 173
Geospiza 8.98 175
GlaxoSmithKline 176 8.99
Glycominds 8.100 176
Health Discovery Corporation 176 8.101
8.102 Corporate Group 178 Hitachi Technology
178 8.103 IBM Life Sciences
ImClone Systems 8.104 179
ImmunoGen 8.105 180
Immunomedics 8.106 181
8.107 Improvement Results 183 software
8.108 184 hits
Incyte Corporation 184 8.109
Informagen 8.110 185
Ingenuity Systems 185 8.111
InNexus 8.112 Biotechnology 186
Insilicos 8.113 186
8.114 186 Intrexon Corporation
Invitrogen Corporation 8.115 187
Computer 8.116 E / S 188
8.117 Johnson & Johnson 188
190 8.118 LabVantage Solutions
Lexigen 8.119 190
8.120 190 Lifespan Biosciences
Lion Bioscience 8.121 190
8.122 191 MathEcology
Matrix Science 191 8.123
Medarex 8.124 191
Medicel 8.125 193
MedImmune 193 8126
Mere 8.127 193
Metabolic Explorer 8.128 194
8.129 194 Metahelix Life Sciences
Metalife 8.130 194
Micromet 8.131 195
Millennium Pharmaceuticals 195 8.132
8.133 molecular connections 196
8.134 196 molecular networks
Molecularware 8.135 196
MorphoSys 8.136 197
Nexus Genomics 197 8.137
8.138 Nonlinear Dynamics 197
Novartis 198 8.139
Ocimum BioSolutions 8.140 199
OmniViz 8.141 200
Partek 8.142 200
PDL BioPharma 8.143 201
Perlegen Sciences 203 8.144
Philogen 8.145 203
Philotec 204 8146
Prokaria 8.147 204
Bioinformatics Quantiom 8.148 204
Relevant software 8.149 205
Roche 8.150 205
Rosetta Inpharmatics 8.151 206
Sanofi-Aventis 8.152 207
SBI Science 209 8.153
Learning 8.154 209 Marina
Seattle Genetics 8.155 210
Scil protein 211 8.156
In addition simulations 8.157 211
Spotfire 8.158 212
8.159 213 Strand Life Sciences
Sun Microsystems 214 8.160
Symphogen 8.161 215
Syngene 8.162 215
8.163 215 Tahoe Computers
Tanox 8.164 215
8.165 216 third Millennium
ThromboGenics 8.166 216
Thomson Reuters 217 8.167
TIB MOLBIOL 8.168 217
Trion Pharma 217 8.169
Tripos 8.170 218
8.171 UBI Life Sciences 218
Viventi 8.172 Biotechnology 219
8.173 219 VizX Labs
220 Wyeth 8.174
Xcellerex 8.175 220
Xencor 8.176 221
8.177 Xoma 221
Xpogen 8.178 223
TABLE OF FIGURES
Figure 4.1: Representation of biotechnology market, geographic, 2008 38
Figure 5.1: Applications of Information Technology over-the Drug Discovery Value Chain 65
Figure 5.2: Functions of Bioinformatics Software in research 65
Figure 5.3: Growth of EMBL database, 66 1995-2008
Figure 5.4: Steps to take a drug to market 71
Figure 5.5: The breakdown of total costs in the development of new drugs 2007 72
Figure 5.6: The Role of Bioinformatics in the Biotechnology Value Chain 78
Figure 5.7: Global pharmaceutical sales and R & D Expenditures, 2000-2013 83
Budget Figure 5.8: Global growth in IT, 2000-2013 84
Figure 5.9: Worldwide Bioinformatics Market, 2000-2013 85
Figure 6.1: Steps of an experiment proteomics 94
Figure 6.2: Architecture Bioinformatics 96
INDEX OF TABLES
Table 2.1: Biotechnology companies 21
Table 2.2: Total domestic R & D USA, 2006-2013 24
Table 2.3: Global Biotechnology Market, 2007 24
Table 2.4: Computer Databases SIB 31
Table 4.1: The Size of the U.S. Biotechnology Industry and income, 2000-2007 37
Table 4.2: Global biotechnology segments 39 Main
Table 4.3: Genomics Sector Market Size, 2006-2013 40
Table 4.4: Total Biochip Market, 2007-2013 41
Table 4.5: Selected Competitors 41 biochip market
Table 4.6: Biochip Microarray Products 41
Table 4.7: 46 Bioinformatics Tools
Table 4.8: Functional Genomics Advanced Building Companies integrated platforms and 49 major databases
Table 4.9: Companies using new genomic tools 50
Table 4.10: Non-chip suppliers based on DNA-51
Table 4.11: Robotics or "Lab-on-a-Chip Market Sector 51
Table 4.12: key high performance and systemic approaches in Genomic Analysis 53
Table 4.13: Pharmacogenomics Segment 56 Players
Table 4.14: Global Pharmacogenomics Market, 2006-2013 56
Table 4.15: Competitors in the segment of 63 SNP genotyping
Table 4.16: Scanning and Detection Technology Providers 64
Table 5.1: Data Sources and Bioinformatics Research 68
Table 5.2: Drivers and Challenges in Bioinformatics Industry 73
Table 5.3: Bioinformatics Activities, Sub-Activities and Key Players 81
Table 5.4: Bioinformatics Market Size, 2006-2013 86
Table 5.5: Market size cheminformatics, 2006-2013 86
Table 5.6: In-silico Computer market size, 2006-2013 86
Table 5.7: Hardware Bioinformatics and systems market size, 2006-2013 87
Table 6.1: Alliances between IT / Telecommunications and Biotechnology Companies 103
Table 6.2: Types of Intellectual Property Protection of Property of bioinformatics tools 108
http://www.aarkstore.com/reports/Bioinformatics-Markets-1172.html
About the Author
Aarkstore Enterprise is a leading provider of business and financial information and solutions worldwide. We specialize in providing online market business information on market research reports, books, magazines, conference at competitive prices, and strive to provide excellent and innovative service to our customers. Our customers include more than 700 leading financial institutions, professional service firms, consulting, law and accounting firms and other corporations throughout the world.
212 Auto marketing strategies. Automated income. Part 1